Role of Multimodality Imaging in the Evaluation and Management of Cardiomyopathy and Heart Failure.

Cardiomyopathies and heart failure (HF) represent a diverse group of cardiac conditions that significantly impact global health. The increasing complexity of these disorders demands more precise tools for diagnosis, risk assessment, and treatment guidance. Over the past decade, multimodality imaging has become a cornerstone in the evaluation of cardiomyopathies, offering distinct advantages in structural, functional, and tissue-level assessment that surpass any single imaging technique. Here, we provide a contemporary review of the role of echocardiography, cardiac magnetic resonance, cardiac computed tomography, nulceare imaging and artificial intelligence applications in cardiomyopathy and HF.